Rexahn Pharmaceuticals to Present at the 17th Annual Rodman and Renshaw Global Investment Conference on September 10, 2015 Aug 31, 2015
Rexahn Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update Aug 10, 2015
Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Targeted Cancer Drug Delivery Platform Jul 14, 2015
Data on Rexahn’s RX-3117 in Non-Small Cell Lung Cancer Presented at 16th International Symposium of the Purine and Pyrimidine Society Jun 9, 2015
National Cancer Institute Accepts Rexahn's RX-21101 for Its Nanotechnology Characterization Laboratory's Preclinical Characterization Program Jun 8, 2015
Rexahn Announces Poster Presentations at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting May 13, 2015
New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer Cells in a Metastatic Cancer Model Apr 21, 2015
Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer Research Annual Meeting Apr 20, 2015